Annovis Bio Stock Jumps As New Data Shows Buntanetap Halts Cognitive Decline In Parkinson's Patients

benzinga.com/news/health-care/25/11/48905832/annovis-bio-stock-jumps-as-new-data-shows-buntanetap-halts-cognitive-decline-in-parkinsons-patie

Small Cap Annovis Bio Inc. (NYSE:ANVS) stock is trading higher on Monday, with a session volume of 12.29 million compared to the average volume of 615.12 thousand as per data from Benzinga Pro.
A late-stage clinical drug platform company focused on neurodegenerative diseases such as…

This story appeared on benzinga.com, 2025-11-17 18:07:04.
The Entire Business World on a Single Page. Free to Use →